⚡ Interrogation des APIs scientifiques en cours…
⚡ Interrogation des APIs scientifiques en cours…
Authors' conclusion
Does not affect the score
Publi-Score
Fidelity
Abstract (PubMed)
Statin use is associated with a slightly increased risk of development of diabetes mellitus, but the absolute risk increase is small, and the cardiovascular and mortality benefits of statin therapy exceed the risk of diabetes in most patients at risk of a cardiovascular event. This collaborative meta-analysis of 13 randomised statin trials (n=91,140) found an odds ratio of 1.09 (95% CI 1.02-1.17) for new-onset diabetes among statin users versus controls. The number needed to harm was 255 patients treated for 4 years. Results were consistent across trials with little heterogeneity.
Coeff. authors = avg(0.65, 0.85) = 0.75
Coeff. editorial = avg(1.00, 0.90) = 0.95
min(0.75, 0.95) = 0.75← lowest dominates
Final coefficient : 0.75
Final score = 47.0/50.8 × 0.75 × 100 = 70/100
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL — 2018 · The New England journal of medicine
Contrasted resultsEzetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP — 2015 · The New England journal of medicine
Contrasted resultsEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Zinman B — 2015 · New England Journal of Medicine
Contrasted resultsMeta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
Hill A — 2021 · Open Forum Infectious Diseases
Contrasted resultsStatin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 t…
Herrett E — 2021 · BMJ (Clinical research ed.)